Next-Generation Biologics Market Report

Japan Next-Generation Biologics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 15, 2019
  • PAGES：219
  • REPORT CODE：GMM240978
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Next-Generation Biologics market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Next-Generation Biologics market. Detailed analysis of key players, along with key growth strategies adopted by Next-Generation Biologics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Sanofi

    • Roche

    • Allergan

    • Eli Lilly

    • Biogen Idec

    • Bayer

    • Molecular Partners

    • Kyowa Hakko Kirin

    • Pfizer

    • Novo Nordisk


    By Type:

    • Antibodies

    • Regenerative medicine

    • Insulins

    • Growth hormones

    • Other


    By End-User:

    • Medical

    • Scientific Research

    • Other


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Next-Generation Biologics Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Next-Generation Biologics Market Size and Growth Rate of Antibodies from 2014 to 2026

      • 1.3.2 Japan Next-Generation Biologics Market Size and Growth Rate of Regenerative medicine from 2014 to 2026

      • 1.3.3 Japan Next-Generation Biologics Market Size and Growth Rate of Insulins from 2014 to 2026

      • 1.3.4 Japan Next-Generation Biologics Market Size and Growth Rate of Growth hormones from 2014 to 2026

      • 1.3.5 Japan Next-Generation Biologics Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Next-Generation Biologics Market Size and Growth Rate of Medical from 2014 to 2026

      • 1.4.2 Japan Next-Generation Biologics Market Size and Growth Rate of Scientific Research from 2014 to 2026

      • 1.4.3 Japan Next-Generation Biologics Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Next-Generation Biologics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Next-Generation Biologics by Major Types

      • 3.4.1 Market Size and Growth Rate of Antibodies

      • 3.4.2 Market Size and Growth Rate of Regenerative medicine

      • 3.4.3 Market Size and Growth Rate of Insulins

      • 3.4.4 Market Size and Growth Rate of Growth hormones

      • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of Next-Generation Biologics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Next-Generation Biologics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Next-Generation Biologics in Medical

      • 4.4.2 Market Size and Growth Rate of Next-Generation Biologics in Scientific Research

      • 4.4.3 Market Size and Growth Rate of Next-Generation Biologics in Other


    5 Market Analysis by Regions

    • 5.1 Japan Next-Generation Biologics Production Analysis by Regions

    • 5.2 Japan Next-Generation Biologics Consumption Analysis by Regions


    6 Hokkaido Next-Generation Biologics Landscape Analysis

    • 6.1 Hokkaido Next-Generation Biologics Landscape Analysis by Major Types

    • 6.2 Hokkaido Next-Generation Biologics Landscape Analysis by Major End-Users


    7 Tohoku Next-Generation Biologics Landscape Analysis

    • 7.1 Tohoku Next-Generation Biologics Landscape Analysis by Major Types

    • 7.2 Tohoku Next-Generation Biologics Landscape Analysis by Major End-Users


    8 Kanto Next-Generation Biologics Landscape Analysis

    • 8.1 Kanto Next-Generation Biologics Landscape Analysis by Major Types

    • 8.2 Kanto Next-Generation Biologics Landscape Analysis by Major End-Users


    9 Chubu Next-Generation Biologics Landscape Analysis

    • 9.1 Chubu Next-Generation Biologics Landscape Analysis by Major Types

    • 9.2 Chubu Next-Generation Biologics Landscape Analysis by Major End-Users


    10 Kinki Next-Generation Biologics Landscape Analysis

    • 10.1 Kinki Next-Generation Biologics Landscape Analysis by Major Types

    • 10.2 Kinki Next-Generation Biologics Landscape Analysis by Major End-Users


    11 Chugoku Next-Generation Biologics Landscape Analysis

    • 11.1 Chugoku Next-Generation Biologics Landscape Analysis by Major Types

    • 11.2 Chugoku Next-Generation Biologics Landscape Analysis by Major End-Users


    12 Shikoku Next-Generation Biologics Landscape Analysis

    • 12.1 Shikoku Next-Generation Biologics Landscape Analysis by Major Types

    • 12.2 Shikoku Next-Generation Biologics Landscape Analysis by Major End-Users


    13 Kyushu Next-Generation Biologics Landscape Analysis

    • 13.1 Kyushu Next-Generation Biologics Landscape Analysis by Major Types

    • 13.2 Kyushu Next-Generation Biologics Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Sanofi

      • 14.1.1 Sanofi Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Roche

      • 14.2.1 Roche Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Allergan

      • 14.3.1 Allergan Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Eli Lilly

      • 14.4.1 Eli Lilly Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Biogen Idec

      • 14.5.1 Biogen Idec Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Bayer

      • 14.6.1 Bayer Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Molecular Partners

      • 14.7.1 Molecular Partners Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Kyowa Hakko Kirin

      • 14.8.1 Kyowa Hakko Kirin Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Novo Nordisk

      • 14.10.1 Novo Nordisk Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 139 Figures and 133 Tables)

     

    • Figure Japan Next-Generation Biologics Market Size and Growth Rate of Antibodies from 2014 to 2026

    • Figure Japan Next-Generation Biologics Market Size and Growth Rate of Regenerative medicine from 2014 to 2026

    • Figure Japan Next-Generation Biologics Market Size and Growth Rate of Insulins from 2014 to 2026

    • Figure Japan Next-Generation Biologics Market Size and Growth Rate of Growth hormones from 2014 to 2026

    • Figure Japan Next-Generation Biologics Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Next-Generation Biologics Market Size and Growth Rate of Medical from 2014 to 2026

    • Figure Japan Next-Generation Biologics Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • Figure Japan Next-Generation Biologics Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Next-Generation Biologics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Next-Generation Biologics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Next-Generation Biologics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Next-Generation Biologics by Different Types from 2014 to 2026

    • Table Consumption Share of Next-Generation Biologics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Antibodies

    • Figure Market Size and Growth Rate of Regenerative medicine

    • Figure Market Size and Growth Rate of Insulins

    • Figure Market Size and Growth Rate of Growth hormones

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Next-Generation Biologics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Next-Generation Biologics by Different End-Users from 2014 to 2026

    • Figure Japan Next-Generation Biologics Market Size and Growth Rate of Medical from 2014 to 2026

    • Figure Japan Next-Generation Biologics Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • Figure Japan Next-Generation Biologics Market Size and Growth Rate of Other from 2014 to 2026

    • Table Japan Next-Generation Biologics Production by Regions

    • Table Japan Next-Generation Biologics Production Share by Regions

    • Figure Japan Next-Generation Biologics Production Share by Regions in 2014

    • Figure Japan Next-Generation Biologics Production Share by Regions in 2018

    • Figure Japan Next-Generation Biologics Production Share by Regions in 2026

    • Table Japan Next-Generation Biologics Consumption by Regions

    • Table Japan Next-Generation Biologics Consumption Share by Regions

    • Figure Japan Next-Generation Biologics Consumption Share by Regions in 2014

    • Figure Japan Next-Generation Biologics Consumption Share by Regions in 2018

    • Figure Japan Next-Generation Biologics Consumption Share by Regions in 2026

    • Table Hokkaido Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Hokkaido Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Next-Generation Biologics Consumption Share by Types in 2014

    • Figure Hokkaido Next-Generation Biologics Consumption Share by Types in 2018

    • Figure Hokkaido Next-Generation Biologics Consumption Share by Types in 2026

    • Table Hokkaido Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Next-Generation Biologics Consumption Share by End-Users in 2014

    • Figure Hokkaido Next-Generation Biologics Consumption Share by End-Users in 2018

    • Figure Hokkaido Next-Generation Biologics Consumption Share by End-Users in 2026

    • Table Tohoku Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Tohoku Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Next-Generation Biologics Consumption Share by Types in 2014

    • Figure Tohoku Next-Generation Biologics Consumption Share by Types in 2018

    • Figure Tohoku Next-Generation Biologics Consumption Share by Types in 2026

    • Table Tohoku Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Tohoku Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Next-Generation Biologics Consumption Share by End-Users in 2014

    • Figure Tohoku Next-Generation Biologics Consumption Share by End-Users in 2018

    • Figure Tohoku Next-Generation Biologics Consumption Share by End-Users in 2026

    • Table Kanto Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Kanto Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Figure Kanto Next-Generation Biologics Consumption Share by Types in 2014

    • Figure Kanto Next-Generation Biologics Consumption Share by Types in 2018

    • Figure Kanto Next-Generation Biologics Consumption Share by Types in 2026

    • Table Kanto Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Kanto Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Next-Generation Biologics Consumption Share by End-Users in 2014

    • Figure Kanto Next-Generation Biologics Consumption Share by End-Users in 2018

    • Figure Kanto Next-Generation Biologics Consumption Share by End-Users in 2026

    • Table Chubu Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Chubu Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Figure Chubu Next-Generation Biologics Consumption Share by Types in 2014

    • Figure Chubu Next-Generation Biologics Consumption Share by Types in 2018

    • Figure Chubu Next-Generation Biologics Consumption Share by Types in 2026

    • Table Chubu Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Chubu Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Next-Generation Biologics Consumption Share by End-Users in 2014

    • Figure Chubu Next-Generation Biologics Consumption Share by End-Users in 2018

    • Figure Chubu Next-Generation Biologics Consumption Share by End-Users in 2026

    • Table Kinki Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Kinki Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Figure Kinki Next-Generation Biologics Consumption Share by Types in 2014

    • Figure Kinki Next-Generation Biologics Consumption Share by Types in 2018

    • Figure Kinki Next-Generation Biologics Consumption Share by Types in 2026

    • Table Kinki Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Kinki Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Next-Generation Biologics Consumption Share by End-Users in 2014

    • Figure Kinki Next-Generation Biologics Consumption Share by End-Users in 2018

    • Figure Kinki Next-Generation Biologics Consumption Share by End-Users in 2026

    • Table Chugoku Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Chugoku Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Next-Generation Biologics Consumption Share by Types in 2014

    • Figure Chugoku Next-Generation Biologics Consumption Share by Types in 2018

    • Figure Chugoku Next-Generation Biologics Consumption Share by Types in 2026

    • Table Chugoku Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Chugoku Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Next-Generation Biologics Consumption Share by End-Users in 2014

    • Figure Chugoku Next-Generation Biologics Consumption Share by End-Users in 2018

    • Figure Chugoku Next-Generation Biologics Consumption Share by End-Users in 2026

    • Table Shikoku Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Shikoku Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Next-Generation Biologics Consumption Share by Types in 2014

    • Figure Shikoku Next-Generation Biologics Consumption Share by Types in 2018

    • Figure Shikoku Next-Generation Biologics Consumption Share by Types in 2026

    • Table Shikoku Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Shikoku Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Next-Generation Biologics Consumption Share by End-Users in 2014

    • Figure Shikoku Next-Generation Biologics Consumption Share by End-Users in 2018

    • Figure Shikoku Next-Generation Biologics Consumption Share by End-Users in 2026

    • Table Kyushu Next-Generation Biologics Consumption by Types from 2014 to 2026

    • Table Kyushu Next-Generation Biologics Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Next-Generation Biologics Consumption Share by Types in 2014

    • Figure Kyushu Next-Generation Biologics Consumption Share by Types in 2018

    • Figure Kyushu Next-Generation Biologics Consumption Share by Types in 2026

    • Table Kyushu Next-Generation Biologics Consumption by End-Users from 2014 to 2026

    • Table Kyushu Next-Generation Biologics Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Next-Generation Biologics Consumption Share by End-Users in 2014

    • Figure Kyushu Next-Generation Biologics Consumption Share by End-Users in 2018

    • Figure Kyushu Next-Generation Biologics Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Biogen Idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec

    • Figure Sales and Growth Rate Analysis of Biogen Idec

    • Figure Revenue and Market Share Analysis of Biogen Idec

    • Table Product and Service Introduction of Biogen Idec

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Molecular Partners

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Molecular Partners

    • Figure Sales and Growth Rate Analysis of Molecular Partners

    • Figure Revenue and Market Share Analysis of Molecular Partners

    • Table Product and Service Introduction of Molecular Partners

    • Table Company Profile and Development Status of Kyowa Hakko Kirin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kyowa Hakko Kirin

    • Figure Sales and Growth Rate Analysis of Kyowa Hakko Kirin

    • Figure Revenue and Market Share Analysis of Kyowa Hakko Kirin

    • Table Product and Service Introduction of Kyowa Hakko Kirin

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US